About Genpathway
Genpathway is a Healthcare company based in Carlsbad (United States) founded in 1999, and was acquired by Active Motif in November 2010. Systems biology company specializing in genome-wide epigenetic studies. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is GENPATHWAY, INC. Its competitors include Chroma Medicine, Reaction Biology and FOXO Technologies; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 1999 in Carlsbad, United States, Genpathway operated in the systems biology sector with a focus on epigenetics. Products such as FactorPath for transcription-factor binding sites, TranscriptionPath for transcribed genes, HistonePath for histone sites, PromoterPath for promoters, and MethylPath for methylated regions were developed. Antibody qualification services for ChIP sequencing were also provided. Acquisition by Active Motif occurred in November 2010 for an undisclosed amount.
- Headquarters Carlsbad, United States
- Stage Acquired
- SectorsHealthcare
- Website genpathway.com
- Social LinkedIn
- Acquired by Active Motif (Nov 2010)
- Legal Name Genpathway, Inc
- Investors
- Acquired byActive Motif
(Nov 2010)
Investors in Genpathway
Genpathway has secured backing from 1 investor. Prominent investors backing the company include Active Motif.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Epigenetics and gene regulation research tools are developed and distributed. | 1999 | activemotif.com | Carlsbad, United States |
Investor details for Genpathway
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genpathway
2 dated milestones of Genpathway across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Genpathway is founded.
- Exit Acquired by Active Motif.
Competitors of Genpathway
Genpathway has 3 listed competitors in our database, 1 of them funded. They include Chroma Medicine, Reaction Biology and FOXO Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromamedicine.com | 2020 | Cambridge, United States | $135M | 122 | Epigenetic editing platform is developed for genomic medicines. | |
| reactionbiology.com | 2001 | United States | 77 | In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling | ||
| foxotechnologies.com | 2020 | Minneapolis, United States | Epigenetic biomarkers are discovered and developed via AI platforms. |
Detailed competitors of Genpathway
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Genpathway (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genpathway
Genpathway was founded in 1999.
Genpathway is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Founded in 1999 in Carlsbad, United States, Genpathway operated in the systems biology sector with a focus on epigenetics. Products such as FactorPath for transcription-factor binding sites, TranscriptionPath for transcribed genes, HistonePath for histone sites, PromoterPath for promoters, and MethylPath for methylated regions were developed. Antibody qualification services for ChIP sequencing were also provided. Acquisition by Active Motif occurred in November 2010 for an undisclosed amount.
Genpathway's top competitors include Chroma Medicine, FOXO Technologies and Reaction Biology.
Genpathway has 1 investor. Key investors include Active Motif.
Genpathway operates through Genpathway, Inc.
Yes. Genpathway was acquired by Active Motif in November 2010.